The relationship between ULK1 expression and the phosphorylation level of Exo70 on Ser89 in clinical breast cancer tissues was then examined using a commercial ULK1 antibody and our anti-phospho-Exo70-Ser89 antibody. Here, ULK1 is linked to breast carcinoma.